Clinical Trials Directory

Trials / Completed

CompletedNCT02452450

Ibuprofen and Paracetamol Pharmacokinetic Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Reckitt Benckiser Healthcare (UK) Limited · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to determine rates of absorption of Ibuprofen and Paracetamol formulations.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen Acid
DRUGIbuprofen Lysine
DRUGIbuprofen Sodium
DRUGIbuprofen Liquid Capsules
DRUGParacetamol

Timeline

Start date
2014-01-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2015-05-22
Last updated
2015-05-27

Source: ClinicalTrials.gov record NCT02452450. Inclusion in this directory is not an endorsement.

Ibuprofen and Paracetamol Pharmacokinetic Study (NCT02452450) · Clinical Trials Directory